Habr, Dany http://orcid.org/0000-0002-3361-6309
Singh, Manmohan http://orcid.org/0000-0002-9175-8559
Uehara, Roberto http://orcid.org/0000-0003-3888-9477
Article History
Received: 3 October 2023
Accepted: 14 November 2023
First Online: 8 December 2023
Declarations
:
: Dany Habr, Manmohan Singh and Roberto Uehara are employees of Pfizer. They report no other conflicts of interest in this work. The results and discussions in this article do not represent or reflect in any way the official policy or position of the current or previous employers of the authors.
: Not applicable; research involved secondary use of data from ClinicalTrials.gov without any identifier(s) which could allow access to private information of any individual. This article does not contain any new studies with human participants or animals performed by any of the authors.